Orviva

Learn · Variants · CYP2B6

rs28399499 CYP2B6

Normal CYP2B6 function at *18 position.

Imported from PharmGKB:2A · not individually reviewed Drug response · dbSNP

What is rs28399499?

rs28399499 is a single-nucleotide polymorphism (SNP) in the CYP2B6 gene (Cytochrome P450 2B6). Each person carries two copies, one from each parent, so a result is reported as a pair of letters such as TT. The table below describes what studies associate with each genotype; the association is statistical, across populations, and is not a diagnosis.

What does each rs28399499 genotype mean?

GenotypeAssociationWhat the evidence saysConfidence
TTtypicalNormal CYP2B6 function at *18 position.85%
TCincreasedCYP2B6 *18 carrier. No enzyme function from this allele. More common in African populations.85%
CCincreasedCYP2B6 *18 homozygous. No enzyme function. Significantly elevated efavirenz levels.85%

Which drugs have annotations for rs28399499?

PharmGKB clinical annotations (level 1A is the strongest evidence, 4 the weakest):

DrugAnnotation typeEvidence level
nevirapineToxicity, Metabolism/PK2A
efavirenzToxicity, Metabolism/PK2A

Is rs28399499 on 23andMe and AncestryDNA chips?

Chip coverage is not recorded for this variant. Orviva reports it when a raw-data file contains it directly or via a well-correlated proxy SNP, and says so when it does not.

Sources

  • PharmGKB:2A
  • Drug:nevirapine
  • Type:Toxicity

Genetic associations describe risk across populations, not a diagnosis for any one person. Most variants shift risk modestly and act alongside lifestyle, environment and other genes. Consumer DNA chips do not read every position and can be wrong at any single one. For general education only; talk to a clinician or genetic counsellor before acting on anything here, and never change a prescribed medicine without your prescriber.